721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines

Detalles Bibliográficos
Autores principales: Khatib, Riad, Sharma, Mamta, Johnson, Leonard, Riederer, Kathleen, Shemes, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
IDWeek 2014 Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781893/
http://dx.doi.org/10.1093/ofid/ofu052.429
_version_ 1783295064907186176
author Khatib, Riad
Sharma, Mamta
Johnson, Leonard
Riederer, Kathleen
Shemes, Stephen
author_facet Khatib, Riad
Sharma, Mamta
Johnson, Leonard
Riederer, Kathleen
Shemes, Stephen
author_sort Khatib, Riad
collection PubMed
description
format Online
Article
Text
id pubmed-5781893
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57818932018-03-01 721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines Khatib, Riad Sharma, Mamta Johnson, Leonard Riederer, Kathleen Shemes, Stephen Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781893/ http://dx.doi.org/10.1093/ofid/ofu052.429 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Khatib, Riad
Sharma, Mamta
Johnson, Leonard
Riederer, Kathleen
Shemes, Stephen
721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
title 721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
title_full 721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
title_fullStr 721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
title_full_unstemmed 721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
title_short 721 Decreasing Prevalence of Vancomycin-Heteroresistance (hVISA) among Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Isolates over 10 years: Potential Impact of Vancomycin Treatment Guidelines
title_sort 721 decreasing prevalence of vancomycin-heteroresistance (hvisa) among methicillin-resistant staphylococcus aureus (mrsa) blood isolates over 10 years: potential impact of vancomycin treatment guidelines
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781893/
http://dx.doi.org/10.1093/ofid/ofu052.429
work_keys_str_mv AT khatibriad 721decreasingprevalenceofvancomycinheteroresistancehvisaamongmethicillinresistantstaphylococcusaureusmrsabloodisolatesover10yearspotentialimpactofvancomycintreatmentguidelines
AT sharmamamta 721decreasingprevalenceofvancomycinheteroresistancehvisaamongmethicillinresistantstaphylococcusaureusmrsabloodisolatesover10yearspotentialimpactofvancomycintreatmentguidelines
AT johnsonleonard 721decreasingprevalenceofvancomycinheteroresistancehvisaamongmethicillinresistantstaphylococcusaureusmrsabloodisolatesover10yearspotentialimpactofvancomycintreatmentguidelines
AT riedererkathleen 721decreasingprevalenceofvancomycinheteroresistancehvisaamongmethicillinresistantstaphylococcusaureusmrsabloodisolatesover10yearspotentialimpactofvancomycintreatmentguidelines
AT shemesstephen 721decreasingprevalenceofvancomycinheteroresistancehvisaamongmethicillinresistantstaphylococcusaureusmrsabloodisolatesover10yearspotentialimpactofvancomycintreatmentguidelines

Ejemplares similares